HomeASND • NASDAQ
add
Ascendis Pharma A/S
Previous close
$126.55
Day range
$124.11 - $128.20
Year range
$86.55 - $161.00
Market cap
7.54B USD
Avg Volume
400.15K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(EUR) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 36.00M | -24.04% |
Operating expense | 157.79M | -9.99% |
Net income | -109.38M | 9.93% |
Net profit margin | -303.85 | -18.58% |
Earnings per share | -1.91 | 11.57% |
EBITDA | -128.87M | 5.38% |
Effective tax rate | -0.21% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 258.70M | -39.99% |
Total assets | 758.30M | -7.95% |
Total liabilities | 1.08B | 42.22% |
Total equity | -321.13M | — |
Shares outstanding | 57.35M | — |
Price to book | -22.60 | — |
Return on assets | -42.69% | — |
Return on capital | -85.17% | — |
Cash Flow
Net change in cash
(EUR) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -109.38M | 9.93% |
Cash from operations | -61.31M | 59.96% |
Cash from investing | 608.00K | -98.71% |
Cash from financing | -2.46M | -6.32% |
Net change in cash | -61.54M | 42.51% |
Free cash flow | -55.69M | 44.02% |
About
Founded
2006
Website
Employees
879